These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 34471044)

  • 21. Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
    Kato H; Hagihara M; Murakami E; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Uno B; Mikamo H
    Chemotherapy; 2018; 63(1):13-19. PubMed ID: 29130946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genotyping and drug resistance of methicillin-resistant Staphylococcus aureus].
    Yao M; Guan L; Jia W; Wang L; Li G; Wu X; Sun T
    Zhonghua Shao Shang Za Zhi; 2014 Oct; 30(5):428-32. PubMed ID: 25572893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.
    Frymoyer A; Hersh AL; Coralic Z; Benet LZ; Joseph Guglielmo B
    Clin Ther; 2010 Mar; 32(3):534-42. PubMed ID: 20399990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.
    Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A
    J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-resistant Staphylococcus aureus in North-east Croatia.
    Pastuović T; Perić M; Bošnjak Z; Ružman N; Majić PR; Talapko J; Atalić V; Loci-Zvocak S; Vuković D
    Acta Med Acad; 2015; 44(1):10-7. PubMed ID: 26062693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ; Barber KE; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
    Lepak AJ; Marchillo K; Pichereau S; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon.
    Setiawan E; Suwannoi L; Montakantikul P; Chindavijak B
    Acta Med Indones; 2019 Jan; 51(1):10-18. PubMed ID: 31073101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).
    Hall RG; Thatcher M; Wei W; Varghese S; Varughese L; Ndiulor M; Payne KD
    Expert Rev Clin Pharmacol; 2017 May; 10(5):493-508. PubMed ID: 28293964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closed-Loop Control for Precision Antimicrobial Delivery: An In Silico Proof-of-Concept.
    Herrero P; Rawson TM; Philip A; Moore LSP; Holmes AH; Georgiou P
    IEEE Trans Biomed Eng; 2018 Oct; 65(10):2231-2236. PubMed ID: 29989937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
    Patel N; Lubanski P; Ferro S; Bonafede M; Harrington S; Evans A; Stellrecht K; Lodise TP
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5141-4. PubMed ID: 19805558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
    Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [No Abstract]   [Full Text] [Related]  

  • 36. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
    Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
    Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.
    Mizokami F; Shibasaki M; Yoshizue Y; Noro T; Mizuno T; Furuta K
    Clin Interv Aging; 2013; 8():1015-21. PubMed ID: 23966773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PREVALENCE AND ANTIBIOTIC SUSCEPTIBLITY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS, COLLECTED AT THAMMASAT UNIVERSITY HOSPITAL, THAILAND, AUGUST 2012 - JULY 2015.
    Phokhaphan P; Tingpej P; Apisarnthanarak A; Kondo S
    Southeast Asian J Trop Med Public Health; 2017 Mar; 48(2):351-9. PubMed ID: 29642297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal teicoplanin dosage regimens for methicillin-resistant Staphylococcus aureus infections in endocarditis patients and renal failure patients.
    Li N; Zhu L; Xu G; Ge T; Qi F; Li M
    J Chemother; 2017 Dec; 29(6):358-364. PubMed ID: 28587526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).
    Payne KD; Das A; Ndiulor M; Hall RG
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):139-149. PubMed ID: 29186999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.